Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BIB NYSEARCA:LABD NYSEARCA:RXL NYSEARCA:SURI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBIBProShares Ultra Nasdaq Biotechnology$88.01+3.5%$83.02$44.20▼$90.90$81.85M1.2410,504 shs5,773 shsLABDDirexion Daily S&P Biotech Bear 3x Shares$10.00-11.4%$13.73$9.79▼$80.69$47.10M-2.464.70 million shs13.20 million shsRXLProShares Ultra Health Care$47.68+1.8%$46.35$36.23▼$55.58$77.24M1.169,402 shs13,592 shsSURISimplify Propel Opportunities ETF$17.08+0.4%$17.32$14.70▼$18.50$77.20M1.097,270 shs224 shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBIBProShares Ultra Nasdaq Biotechnology0.00%+2.66%+3.72%+11.94%+87.19%LABDDirexion Daily S&P Biotech Bear 3x Shares0.00%-14.40%-21.10%-43.24%-85.28%RXLProShares Ultra Health Care0.00%-5.53%-1.29%+4.14%+19.25%SURISimplify Propel Opportunities ETF0.00%-2.91%-3.84%+1.98%+5.85%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBIBProShares Ultra Nasdaq Biotechnology$88.01+3.5%$83.02$44.20▼$90.90$81.85M1.2410,504 shs5,773 shsLABDDirexion Daily S&P Biotech Bear 3x Shares$10.00-11.4%$13.73$9.79▼$80.69$47.10M-2.464.70 million shs13.20 million shsRXLProShares Ultra Health Care$47.68+1.8%$46.35$36.23▼$55.58$77.24M1.169,402 shs13,592 shsSURISimplify Propel Opportunities ETF$17.08+0.4%$17.32$14.70▼$18.50$77.20M1.097,270 shs224 shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBIBProShares Ultra Nasdaq Biotechnology0.00%+2.66%+3.72%+11.94%+87.19%LABDDirexion Daily S&P Biotech Bear 3x Shares0.00%-14.40%-21.10%-43.24%-85.28%RXLProShares Ultra Health Care0.00%-5.53%-1.29%+4.14%+19.25%SURISimplify Propel Opportunities ETF0.00%-2.91%-3.84%+1.98%+5.85%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBIBProShares Ultra Nasdaq Biotechnology 2.72Moderate Buy$87.68-0.63% DownsideLABDDirexion Daily S&P Biotech Bear 3x Shares 0.00N/AN/AN/ARXLProShares Ultra Health Care 2.76Moderate Buy$47.780.14% UpsideSURISimplify Propel Opportunities ETF 2.58Moderate Buy$17.10N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBIBProShares Ultra Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/ALABDDirexion Daily S&P Biotech Bear 3x SharesN/AN/AN/AN/AN/AN/ARXLProShares Ultra Health CareN/AN/AN/AN/AN/AN/ASURISimplify Propel Opportunities ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBIBProShares Ultra Nasdaq BiotechnologyN/AN/A20.68N/AN/AN/AN/AN/AN/ALABDDirexion Daily S&P Biotech Bear 3x SharesN/AN/AN/AN/AN/AN/AN/AN/AN/ARXLProShares Ultra Health CareN/AN/A24.86N/AN/AN/AN/AN/AN/ASURISimplify Propel Opportunities ETFN/AN/AN/AN/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBIBProShares Ultra Nasdaq Biotechnology$0.490.56%N/AN/AN/ALABDDirexion Daily S&P Biotech Bear 3x Shares$0.949.56%N/AN/AN/ARXLProShares Ultra Health Care$0.751.57%N/AN/AN/ASURISimplify Propel Opportunities ETF$2.7215.91%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBIBProShares Ultra Nasdaq BiotechnologyN/ALABDDirexion Daily S&P Biotech Bear 3x SharesN/ARXLProShares Ultra Health CareN/ASURISimplify Propel Opportunities ETFN/AInsider OwnershipCompanyInsider OwnershipBIBProShares Ultra Nasdaq BiotechnologyN/ALABDDirexion Daily S&P Biotech Bear 3x SharesN/ARXLProShares Ultra Health CareN/ASURISimplify Propel Opportunities ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBIBProShares Ultra Nasdaq BiotechnologyN/A930,000N/AOptionableLABDDirexion Daily S&P Biotech Bear 3x SharesN/A4.71 millionN/ANot OptionableRXLProShares Ultra Health CareN/A1.62 millionN/ANot OptionableSURISimplify Propel Opportunities ETFN/A4.52 millionN/ANot OptionableSURI, LABD, RXL, and BIB HeadlinesRecent News About These CompaniesSimplify Propel Opportunities ETF declares $0.68 dividendJune 30, 2025 | seekingalpha.comSimplify Propel Opportunities ETF declares quarterly distribution of $0.6800March 28, 2025 | seekingalpha.comSimplify Provides Estimated Capital Gain Distribution Information for 2024November 27, 2024 | businesswire.com(SURI) Trading ReportNovember 7, 2024 | news.stocktradersdaily.comNSimplify Propel Opportunities ETF (SURI)October 20, 2024 | investing.comSURI Simplify Propel Opportunities ETFOctober 18, 2024 | seekingalpha.com(SURI) On The My Stocks PageOctober 16, 2024 | news.stocktradersdaily.comNBest-Performing ETFs of Last WeekSeptember 24, 2024 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 2026Why These 2 Hotel Stocks Are Beating Travel PeersBy Dan Schmidt | June 13, 2026Tomato Prices Are Spiking, and These 2 Food Stocks Could Feel the SqueezeBy Dan Schmidt | June 3, 2026How the Memory Shortage Is Crushing the Gaming IndustryBy Dan Schmidt | June 4, 20263 Long-Duration Treasury ETFs to Watch if Rates FallBy Nathan Reiff | June 15, 2026SURI, LABD, RXL, and BIB Company DescriptionsProShares Ultra Nasdaq Biotechnology NASDAQ:BIB$88.01 +2.99 (+3.52%) Closing price 04:00 PM EasternExtended Trading$88.05 +0.04 (+0.04%) As of 05:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in derivatives that have similar daily performance characteristics as the inverse of the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.Direxion Daily S&P Biotech Bear 3x Shares NYSEARCA:LABD$10.00 -1.29 (-11.43%) As of 04:10 PM EasternThe Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed by Direxion.ProShares Ultra Health Care NYSEARCA:RXL$47.68 +0.85 (+1.82%) Closing price 04:10 PM EasternExtended Trading$47.64 -0.03 (-0.07%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ProShares Ultra Health Care (the Fund) seeks daily investment results that correspond to twice (200%) the daily performance of the Dow Jones U.S. Health Care Index (the Index). The Fund intends to invest at least 80% of its net assets, including any borrowings for investment purposes, under normal circumstances, to equity securities contained in the Index and/or financial instruments that, in combination, have similar economic characteristics. The Fund also intends to invest assets not invested in financial instruments, in debt instruments and/or money market instruments. The Fund intends to concentrate its investments in a particular industry or group of industries to approximately the same extent as the Index is so concentrated. ProShare Advisors LLC serves as the investment advisor to the Fund.Simplify Propel Opportunities ETF NYSEARCA:SURI$17.08 +0.06 (+0.35%) As of 04:10 PM EasternThe Simplify Propel Opportunities ETF (SURI) is an exchange-traded fund that mostly invests in target outcome asset allocation. The fund employs an actively managed, multi-asset strategy that focuses on equity and debt securities of companies in the healthcare sector. The fund selects securities believed to be attractive investment opportunities SURI was launched on Feb 7, 2023 and is managed by Simplify. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Buy CrowdStrike Before the Stock Split? Here's the Case USA Today's Digital Revival Is Gaining Steam, But With Plenty of Risk Burlington Is Winning Over Shoppers But Investors Need Patience Investors Are Buying Into Sweetgreen Again—Should They? MarketBeat Week in Review – 06/15 - 06/19 Cheesecake Factory Stock Is Up Over 50%—Is There Room for More CAKE? Applied Materials Stock Looks Pricey—Can AI Demand Justify the Rally? Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
